Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes

被引:2
作者
Giuliani, Maria Elisa [1 ,2 ]
Bigossi, Giorgia [1 ,2 ]
Lai, Giovanni [1 ,2 ]
Marcozzi, Serena [1 ,2 ]
Brunetti, Dario [3 ,4 ]
Malavolta, Marco [1 ,2 ]
机构
[1] IRCCS INRCA, Adv Technol Ctr Aging Res, I-60121 Ancona, Italy
[2] IRCCS INRCA, Geriatr Mouse Clin, I-60121 Ancona, Italy
[3] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, I-20126 Milan, Italy
[4] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
关键词
ageing; cardiovascular disease; type 2 diabetes mellitus; marine compounds; in vivo studies; clinical trials; OLIGOSACCHARIDES ATTENUATE HYPERTENSION; ALLEVIATES POSTPRANDIAL HYPERGLYCEMIA; ENZYME INHIBITORY PEPTIDES; ACTIVATED PROTEIN-KINASE; BUTYL-ISOBUTYL-PHTHALATE; ALPHA-AMYLASE INHIBITOR; CLAVA FLESH TISSUE; IN-VIVO; ECKLONIA-CAVA; INSULIN-RESISTANCE;
D O I
10.3390/md22050210
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ageing represents a main risk factor for several pathologies. Among them, cardiovascular diseases (CVD) and type 2 diabetes mellitus (T2DM) are predominant in the elderly population and often require prolonged use of multiple drugs due to their chronic nature and the high proportion of co-morbidities. Hence, research is constantly looking for novel, effective molecules to treat CVD and T2DM with minimal side effects. Marine active compounds, holding a great diversity of chemical structures and biological properties, represent interesting therapeutic candidates to treat these age-related diseases. This review summarizes the current state of research on marine compounds for the treatment of CVD and T2DM, from pre-clinical studies to clinical investigations and approved drugs, highlighting the potential of marine compounds in the development of new therapies, together with the limitations in translating pre-clinical results into human application.
引用
收藏
页数:22
相关论文
共 186 条
  • [1] A comprehensive review on the research progress of PTP1B inhibitors as antidiabetics
    Agrawal, Neetu
    Dhakrey, Parth
    Pathak, Shilpi
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 102 (04) : 921 - 938
  • [2] Marine-Derived Compounds Applied in Cardiovascular Diseases: Submerged Medicinal Industry
    Akram, Wasim
    Rihan, Mohd
    Ahmed, Sakeel
    Arora, Swamita
    Ahmad, Sameer
    Vashishth, Rahul
    [J]. MARINE DRUGS, 2023, 21 (03)
  • [3] Immunomodulatory properties of frondoside A, a major triterpene glycoside from the North Atlantic commercially harvested sea cucumber Cucumaria frondosa
    Aminin, D. L.
    Agafonova, I. G.
    Kalinin, V. I.
    Silchenko, A. S.
    Avilov, S. A.
    Stonik, V. A.
    Collin, P. D.
    Woodward, C.
    [J]. JOURNAL OF MEDICINAL FOOD, 2008, 11 (03) : 443 - 453
  • [4] The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation
    Ampofo, Emmanuel
    Spaeter, Thomas
    Nalbach, Lisa
    Menger, Michael D.
    Laschke, Matthias W.
    [J]. MARINE DRUGS, 2020, 18 (02)
  • [5] The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity
    Ampofo, Emmanuel
    Spaeter, Thomas
    Mueller, Isabelle
    Eichler, Hermann
    Menger, Michael D.
    Laschke, Matthias W.
    [J]. MARINE DRUGS, 2015, 13 (11): : 6774 - 6791
  • [6] [Anonymous], 2020, Decade of healthy ageing: baseline report
  • [7] In vitro and in vivo anti-diabetic and anti-hyperlipidemic effects of protein hydrolysates from Octopus vulgaris in alloxanic rats
    Ben Slama-Ben Salem, Rabeb
    Ktari, Naourez
    Bkhairia, Intidhar
    Nasri, Rim
    Mora, Leticia
    Kallel, Rim
    Hamdi, Safa
    Jamoussi, Kamel
    Boudaouara, Tahia
    El-Feki, Abdelfettah
    Toldra, Fidel
    Nasri, Moncef
    [J]. FOOD RESEARCH INTERNATIONAL, 2018, 106 : 952 - 963
  • [8] Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI [10.1161/CIR.0000000000000746, 10.1161/CIR.0000000000000659]
  • [9] Understanding Infection-Induced Thrombosis: Lessons Learned From Animal Models
    Beristain-Covarrubias, Nonantzin
    Perez-Toledo, Marisol
    Thomas, Mark R.
    Henderson, Ian R.
    Watson, Steve P.
    Cunningham, Adam F.
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [10] α-Glucosidase Inhibition and the In Vivo Hypoglycemic Effect of Butyl-isobutyl-phthalate derived from the Laminaria japonica Rhizoid
    Bu, Tong
    Liu, Ming
    Zheng, Lanhong
    Guo, Yuewei
    Lin, Xiukun
    [J]. PHYTOTHERAPY RESEARCH, 2010, 24 (11) : 1588 - 1591